- Home
- KZIA vs NVVE Comparison
KZIA vs NVVE Comparison
Compare KZIA & NVVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KZIA
- NVVE
- Stock Information
- Founded
- KZIA 1994
- NVVE 1996
- Country
- KZIA Australia
- NVVE United States
- Employees
- KZIA N/A
- NVVE N/A
- Industry
- KZIA Biotechnology: Pharmaceutical Preparations
- NVVE Oil Refining/Marketing
- Sector
- KZIA Health Care
- NVVE Energy
- Exchange
- KZIA Nasdaq
- NVVE Nasdaq
- Market Cap
- KZIA 5.1M
- NVVE 5.5M
- IPO Year
- KZIA 1999
- NVVE N/A
- Fundamental
- Price
- KZIA $6.10
- NVVE $0.88
- Analyst Decision
- KZIA Strong Buy
- NVVE
- Analyst Count
- KZIA 2
- NVVE 0
- Target Price
- KZIA $57.50
- NVVE N/A
- AVG Volume (30 Days)
- KZIA 2.6M
- NVVE 2.8M
- Earning Date
- KZIA 07-07-2025
- NVVE 08-12-2025
- Dividend Yield
- KZIA N/A
- NVVE N/A
- EPS Growth
- KZIA N/A
- NVVE N/A
- EPS
- KZIA N/A
- NVVE N/A
- Revenue
- KZIA $1,549,158.00
- NVVE $5,440,777.00
- Revenue This Year
- KZIA N/A
- NVVE $892.33
- Revenue Next Year
- KZIA N/A
- NVVE N/A
- P/E Ratio
- KZIA N/A
- NVVE N/A
- Revenue Growth
- KZIA 248983.08
- NVVE N/A
- 52 Week Low
- KZIA $2.86
- NVVE $0.82
- 52 Week High
- KZIA $79.00
- NVVE $8.80
- Technical
- Relative Strength Index (RSI)
- KZIA 50.96
- NVVE 42.76
- Support Level
- KZIA $5.83
- NVVE $1.22
- Resistance Level
- KZIA $9.60
- NVVE $1.54
- Average True Range (ATR)
- KZIA 1.19
- NVVE 0.16
- MACD
- KZIA -0.29
- NVVE -0.04
- Stochastic Oscillator
- KZIA 18.39
- NVVE 9.73
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.
About NVVE Nuvve Holding Corp.
Nuvve Holding Corp is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. It helps to support the integration of renewable energy sources, including solar and wind. Its Grid Integrated Vehicle (GIV) platform is refueling the next generation of electric vehicle fleets through bidirectional charging solutions. It has a geographic presence in the United States, the United Kingdom, and Denmark, of which it generates the majority of its revenue in the United States.